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Abstract
Viruses are the most common source of infection among immunocompetent individuals, yet they are not considered a
clinically meaningful risk factor among the critically ill. This work examines the association of viral infections diagnosed
during the hospital stay or not documented as present on admission to the outcomes of ICU patients with no evidence of
immunosuppression on admission. This is a population-based retrospective cohort study of University HealthSystem
Consortium (UHC) academic centers in the U.S. from the years 2006 to 2009. The UHC is an alliance of over 90% of the non-
profit academic medical centers in the U.S. A total of 209,695 critically ill patients were used in this analysis. Eight hospital
complications were examined. Patients were grouped into four cohorts: absence of infection, bacterial infection only, viral
infection only, and bacterial and viral infection during same hospital admission. Viral infections diagnosed during
hospitalization significantly increased the risk of all complications. There was also a seasonal pattern for viral infections.
Specific viruses associated with poor outcomes included influenza, RSV, CMV, and HSV. Patients who had both viral and
bacterial infections during the same hospitalization had the greatest risk of mortality RR 6.58, 95% CI (5.47, 7.91); multi-
organ failure RR 8.25, 95% CI (7.50, 9.07); and septic shock RR 271.2, 95% CI (188.0, 391.3). Viral infections may play a
significant yet unrecognized role in the outcomes of ICU patients. They may serve as biological markers or play an active
role in the development of certain adverse complications by interacting with coincident bacterial infection.
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Introduction
Viruses are ubiquitous in the environment and are the most
common source of infection among immunocompetent individu-
als. Despite their pervasiveness, viral infections are generally not
considered to be of clinical significance among the critically ill,
unless the patient is significantly immuncompromised. Much is
known about the progression of viral infections as opportunistic
pathogens among immunocompromised patients while little is
known about their role in patients who are immunocompetent
before hospitalization. Even among patients with no history of
immunosuppression, reactivation of viral herpes viruses (cytomeg-
alovirus (CMV) and herpes simplex virus (HSV)) has been
documented in critically ill [1–10]. This suggests that at least for
some critically ill patients with no pre-hospital diagnosis of
immunosuppression, newly acquired or reactivation of viral
infections during hospitalization can be clinically significant in
this patient population.
Using a large population based database, we sought to examine
the association of viral infections to the outcomes of ICU patients
with no evidence of infection or immunosuppression on admission,
and to identify potential variables amenable to intervention. We
hypothesize that acquired viral infections during hospitalization
may carry their own risk for adverse outcomes among patients in
the intensive care unit.
Methods
Data Source and Study Population
A population based retrospective cohort study using the
University HealthSystem Consortium (UHC) Database, specifi-
cally searching the Resource Manager and Clinical Database
within the UHC system, was conducted. The UHC is comprised
of 103 academic institutions and 210 affiliate institutions
representing over 90% of all academic medical centers in the
United States. The UHC database is an administrative database,
comprised of International Classification of Disease-9 (ICD-9)
diagnosis and procedure codes. At present, it is the only population
based dataset to contain information on the critically ill and their
exposure to viral and bacterial infections.
Only patients without a diagnosis of infection present on
admission were included in the study. The inclusion criteria
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18890included immunocompetent ICU patients greater than or equal to
eighteen years of age admitted to the hospital between the third
quarter, 2006, and second quarter, 2009. Patients with a primary
or secondary ICD 9 code signifying a history of organ
transplantation, human immunodeficiency virus (HIV) or acquired
immunodeficiency syndrome (AIDS), autoimmune disease, leuke-
mia, pancytopenia, or lymphoma were excluded. Immunocompe-
tency was defined as the absence of the aforementioned diagnoses.
A total 209,695 patients met the study criteria.
Study Cohorts and Outcomes
ICD-9 codes present at hospital discharge were used to divide
patients into four cohorts: (1) individuals without a documented
infection (negative); (2) those who were diagnosed with a viral
infection during their hospitalization (viral); (3) those with a
documented bacterial infection (bacterial) during their hospitaliza-
tion;and, (4)thosewho were diagnosedwithboth bacterialand viral
infectionsduringthe samehospitaladmission(coincident).Although
the dataset does not allow us to determine if the infections
overlapped or occurred simultaneously, we referred to this cohort as
‘‘coincident’’ for simplification. The reference group for all relative
risk calculations was the group which did not have a documented
infection.Forpneumonia,sepsis,and septicshock,diagnosesthat by
definition require the presence of an infection for diagnosis, a subset
analysis was also performed using the bacterial cohort as the
reference group. Six hundred ninety-eight documented viral
infections were identified. Eight outcomes frequently encountered
inICU patients were analyzed; death,pneumonia, acute respiratory
distress syndrome (ARDS), respiratory failure, diarrhea, multi-
system organ failure (MSOF), sepsis, and septic shock.
Analysis
Statistical analysis was performed with SAS (version 9.2; SAS Inc.,
Cary, NC). Parametric data expressed as proportions were evaluated
by Chi Square tests, while nonparametric data were evaluated by
Fisher’s exact test. ANOVA was used to calculate p-values for
multiple proportions. Multivariate analysis by Poisson regression was
used to calculate the univariate and multivariate adjusted relative
risks of each exposure group. Variables were identified as potential
confounders if it could be rationalized that an independent effect on
both the exposure and outcome occurred without influencing the
pathway of interest. The final multivariate regression included age,
gender, race, and hospital cluster. Adjustment for hospital cluster
accounts for patient volume and prevents over or under represen-
tation by hospital size. Seasonal distribution of infections was
determined using the hospital admission date. The Cochran-
Armitage test was used to test for trend. ICD 9 codes for common
respiratory and gastrointestinal tract viruses were used to determine
which organisms alone or in combination with a bacterial infection
are associated with the outcomes of interest.
Measures of potential biological interaction between bacterial
and viral coincident infections were estimated by deviation from
additivity methods described by Rothman and others [11–13]. This
method requires the calculation of the RERI (relative risk due to
interaction),AP(attributable riskproportionduetointeraction),and
S (the synergy index). No biological interaction is present when the
RERI and AP are equal to zero and synergy index is equal to one.
Results
Significant differences did exist among socio-demographic
characteristics of the cohorts, most notably age and average
hospital length of stay (Table 1). There was seasonal variation for
viral infections. The seasonal distribution of infections for each
cohort increased from spring to winter, however only the viral and
coincident cohorts exhibited a linear pattern (Figure 1). There
were significantly more documented bacterial infections compared
to both viral and coincident infections. Comparing disease
proportions, the coincident cohort tended to have higher
frequencies for each adverse outcome (Figure 2). Notably, length
of stay was also highest in the coincident group. The average
length of stay was 11.5 days for the negative cohort, 21 days for the
virus cohort, 32 days for the bacteria group, and 46.2 days for the
coincident cohort (p-value ,0.05).
The relative risk (RR) for each outcome according to risk group is
shown in Table S1. Viral, bacterial, and coincident cohorts were at
risk for all adverse events compared to the reference groups.
Coincident infections had the strongest associations with adverse
events, especially for mortality RR 6.58 95% CI (5.47, 7.91); MSOF
RR 8.25 95% CI (7.50, 9.07); and septic shock RR 271.2 95% CI
(188.0, 391.3) when negative was used as the reference group. For
these three adverse events, the confidence intervals among the
coincident cohort were beyond the confidence intervals of either the
viral or bacterial only cohorts. When bacterial infection was used as
the reference group, viral infections were associated with an increased
risk of pneumonia RR 1.30 95% CI (1.10, 1.55), sepsis RR 1.18 95%
CI (1.10, 1.28), and septic shock RR 1.48 95% CI (1.23, 1.78).
Table S2 lists the relative risks for each outcome according to
infecting organism. An increased risk of death was associated with
several viral species including coronavirus, CMV, HSV, influenza
virus, and respiratory syncytial virus (RSV). The combination of
influenza with a bacterial infection was associated with pneumonia
RR 4.65, 95% CI (3.22, 6.70), respiratory failure RR 4.21, 95%
CI (2.39, 7.40), diarrhea RR 4.38 95% CI (1.28, 14.98), MSOF
RR 5.17, 95% CI (3.38, 7.91) sepsis RR 45.1, 95% CI (28.1, 72.6),
and septic shock RR 122.2, 95% CI (33.9, 440.2). Influenza alone
was only associated with an increased risk of respiratory failure
3.19, 95% CI (1.96, 5.17). CMV alone RR 4.69, 95% CI (2.95,
6.28) and with bacterial infection RR 4.30, 95% CI (2.95, 6.28)
were associated with an increased risk of pneumonia. HSV with
bacterial infection (RR 4.28 95% CI 3.23, 5.67) and alone (RR
3.60 95% CI2.68, 4.85) were associated with an increased risk of
pneumonia. Adenovirus and coronavirus with bacterial infection
as well as RSV alone were also associated with pneumonia.
MSOF was associated with the presence of CMV RR 4.79, 95%
CI (8.64, 11.90) as well as HSV RR 2.37, 95% CI (1.62, 3.46). The
presence of CMV, HSV, and influenzaviruswith bacterial infection
was associated with an increased risk of septic shock; RR 218.7 95%
CI (128.1, 373.4), 309.2 (211.6, 452.0), 122.2 (33.9, 440.2),
respectively. HSV in the absence of bacterial infection was also
associated with septic shock, RR 33.71, 95% CI (11.78, 96.41).
There was significant biological interaction between viral and
bacterial infections for septic shock, MSOF, and death. For septic
shock, the risk excess, or RERI, due to the interaction between viral
and bacterial infection was 127.7 95% CI (32.8, 222.5); the
attributable proportionor AP was 0.23 95% CI (0.27, 0.51);and the
synergy index was significant at 1.5 95% CI (1.2, 1.9). For MSOF,
the RERI was significant at 10.6 95% CI (5.1, 15.9); AP was 0.43
95% CI (0.32, 0.58); and the synergy index was significant at 1.9
95% CI (1.5, 2.4). Although the RERI was not significant for death,
the AP and synergy index were significant at 0.28 95% CI (0.046,
0.45) and 1.39 95% CI (1.02, 1.88) respectively.
Discussion
Viral infections diagnosed after hospital admission may play a
significant yet unrecognized role in the outcomes of ICU patients.
While they are the most common organism of infection in
Influence of Viral Infections among Critically Ill
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serious risk factor for those critically ill patients who are admitted
to the ICU without a diagnosis of infection or known
immunosuppression. Few studies have examined the role of
specific viral infections among patients who are immunocompe-
tent before admission into the ICU despite the fact that there is no
data to support that these patients are less likely to develop viral
infections in this setting compared to their immunocompromised
counterparts. Thus the implications of any positive findings may
have the potential to affect all ICU patients.
The results of this population based study show that when a
viral infection is present either alone or during the same
hospitalization as a bacterial infection, it is associated with an
increased risk of mortality, pneumonia, ARDS, respiratory failure,
diarrhea, MSOF, sepsis, and septic shock. Perhaps the most
significant finding is that coincident infections show the strongest
association with each adverse outcome. This is particularly true for
death, septic shock and MSOF where the test for synergistic
interaction is significant. In addition for MSOF and death, the
95% confidence interval is outside the bounds of the other risk
Table 1. Risk group sociodemographics.
Negative Viral Infection Coincident Infection Bacterial Infection p-values
N=190,386 N=370 N=328 N=18, 611
Gender
Male 53.2% 52.4% 53.1% 53.9% 0.28
Female 46.8% 47.6% 46.9% 46.1% 0.28
Race
White 68.8% 66.9% 65.1% 65.7% ,0.0001
Black 15.3% 16.3% 15.3% 17.9% ,0.0001
Hispanic 7.0% 8.9% 7.3% 6.6% 0.19
Asian 2.4% 2.7% 5.5% 2.8% ,0.0001
Others 6.6% 5.2% 6.7% 6.9% 0.16
Age (yrs)
18,20 3.0% 1.1% 2.4% 2.1% ,0.0001
21,30 9.7% 7.6% 4.3% 6.7% ,0.0001
31,40 10.4% 10.0% 7.9% 7.8% ,0.0001
41,50 15.9% 17.3% 17.1% 13.5% ,0.0001
51,60 20.3% 29.5% 27.1% 20.6% ,0.0001
61,70 19.0% 18.9% 22.6% 20.9% ,0.0001
71,80 14.3% 10.3% 12.5% 17.7% ,0.0001
.80 7.4% 5.4% 6.1% 10.6% ,0.0001
Mean Age 54.8 54.8 56.7 58.7
Median Age 56 55 58 60
Maximum Age 108 91 96 107
Minimum Age 18 18 19 18
Insurance Status
Commercial/Private 37.4% 33.8% 32.0% 27.1% ,0.0001
Medicaid 11.5% 19.2% 18.3% 14.2% ,0.0001
Medicare 35.9% 34.1% 36.6% 45.4% ,0.0001
State Assisted Healthcare 1.2% 1.4% 1.5% 1.0% 0.02
Military 1.4% 0.8% 1.5% 1.2% 0.13
Auto Insurance 2.2% 1.4% 0.9% 2.2% 0.25
Workers Compensation 1.6% 1.4% 2.1% 1.2% 0.0008
Research 0.03% 0% 0% 0.03% 0.97
Title V Maternal & Child Health 0.03% 0% 0% 0.06% 0.37
County Medically Indigent
Services
1.0% 0.8% 1.2% 0.9% 0.62
Charity 1.0% 1.6% 0.9% 0.9% 0.27
Self-Pay 5.1% 3.5% 3.7% 3.9% ,0.0001
Other NOS 1.0% 1.4% 0.9% 1.2% 0.004
Unknown 0.7% 0.8% 0.3% 0.7% 0.62
doi:10.1371/journal.pone.0018890.t001
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own independent association. In the subset analysis, viral specific
associations were also found to be significant. For viruses that are
latent and are known to reactivate, CMV and HSV were
significantly associated with mortality, pneumonia, ARDS,
respiratory failure, diarrhea, MSOF, sepsis, and septic shock.
Patients with viruses that have an active phenotype such as
adenovirus, coronavirus, RSV, and influenza virus had a
significant risk of death, pneumonia, respiratory failure, MSOF,
sepsis and septic shock.
If the association between viral infections and immunocompe-
tent ICU patients represents a true clinical relationship, then these
findings have several potential implications. These implications
range from viral infections as markers for disease to viral infections
participating in the causal pathway of complications such as
ARDS and MSOF as well as the occurrence of other infections.
Some of our findings have already been confirmed in recent
literature, such as the link between CMV and HSV with mortality,
pulmonary disease, sepsis, and overall poor patient outcomes [1–
3,5–10,14–19]. Studies have reported reactivation of CMV and
HSV in up to 35% and 64% of critically ill patients, respectively
[8–10,16,17,20]. In a study involving patients with ventilator
associated pneumonia, Luyt et al reported 21% of patients with
HSV isolated from bronchoalveolar lavage (BAL) specimens had
HSV bronchopneumonitis [8]. It is reasonable to assume that a
significant proportion of critically ill patients are at risk for
reactivation of these herpes viruses. Between 50% and 80% of the
population is CMV-seropositive by age 40 years and 72% of the
population aged 14–19 years is seropositive for HSV-1 and HSV-2
combined. [6,9,18,19,21–23] In our study, HSV was associated
with an increased risk of each outcome while CMV was
not associated with sepsis or septic shock in patients without
an additional documented bacterial infection during their
hospitalization.
Some have suggested that viral detection does not equate to
viral disease. However, it may serve as a marker for increased risk
of disease development. van den Brink et al addressed the concept
of viral reactivation as a marker as opposed to a mediator of
pulmonary disease in patients with HSV-1 isolated from
bronchoalveolar lavage (BAL) samples [21]. The results of our
study also suggest that there is an independent association of death
and MSOF among patients who develop both a viral and bacterial
infection during their hospitalization. MSOF has been attributed
to septic shock secondary to bacteremia, but there are patients
who may not develop MSOF despite the presence of bacteremia.
The relationship of viral infections to outcomes in the ICU is
more complicated than the documentation of viral infection. The
mechanism and extent to which viruses cause disease is diverse.
Viruses belonging to the Herpesviridae family are known for their
ability to become dormant in host cells while other viruses such as
influenza virus, adenovirus, RSV, and coronavirus are only
capable of causing disease at the time of infection. RSV, the only
non herpes virus in our study associated with death in the absence
of bacterial infection, carried the highest risk of mortality. RSV is a
Figure 1. Proportion of individual risk groups by season.
doi:10.1371/journal.pone.0018890.g001
Figure 2. Frequency of adverse outcomes.
doi:10.1371/journal.pone.0018890.g002
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infection unless the patients were mechanically ventilated or had a
nasogastric tube in place. Rouby et al demonstrated an association
between oral and nasal intubation with the development of
sinusitis which facilitates respiratory infections in the ICU [24].
The concept of bacterial superinfection is common in viral
respiratory illnesses [25]. Epidemiological evidence of synergistic
relationships between viruses and bacteria can be seen in influenza
pandemics where an increased incidence of Staphylococcus aureus
pneumonia was encountered as well as an increased incidence of
bacterial otitis media associated with both RSV and influenza
virus [26]. Viral infections may facilitate bacterial colonization by
damaging host respiratory epithelium, making bacterial adherence
or invasion easier. Preceding or intercurrent viral infections may
down regulate the host immune response leading to subsequent
bacterial infection [25,26]. It is therefore possible that treatment of
viral infection or viral reactivation in this setting may mitigate
against the association with poor outcomes seen in coincident
infection.
The limitations inherent in this study are the degree of bias, the
inability to infer causality, and classification of critically ill patients
as immunocompetent. While the purpose of this study was to
identify associations, it is also meant to promote hypothesis
generation to encourage prospective studies that will address
causality. We defined immunocompetent as the absence of several
diagnoses associated with immunosuppression. While classifying
patients in the ICU as having acquired immunosuppression due to
prolonged critical illness appears to be a valid assumption, this is
supported by limited rigorous scientific data. Therefore the
premise remains controversial. Although studies have demonstrat-
ed alterations in immune system function in the critically ill, this
may represent a transition along the spectrum of immunocompe-
tency opposed to true immunosuppression. Another limitation
found in administrative databases is the lack of clinical data. Key
variables are missing to ascertain the site from which the virus was
isolated or the order of clinical events. We do know these
infections occurred within the same hospitalization, were not
documented as present on admission, and were significantly
associated with worse patient outcomes. Considering viral
infections are rarely diagnosed in the ICU, it is possible that only
those patients who were most critically ill were tested for viral
infections. Thus, the effect we see is one of severity of critical illness
instead of viral association. However, patients with only viral
infections actually had less risk of adverse outcomes compared to
their bacterial and coincident counterparts. This may reject some
of this bias. It is likely that viral infections were rarely thought of as
the source of poor outcomes among patients whose pre-hospital
status was not immunocompromised. Because the denominator of
active viral infection among the critically ill is not known, the data
presented in this paper may significantly underestimate the impact
of viral infections in this setting. Despite many of these limitations,
this is the only population based dataset that has documented
hospital acquired viral infections among the critically ill.
In conclusion, viral infections may play a very important role in
the overall outcome of critically ill patients who were immuno-
competent before hospital admission. Viral infections may
represent an unrecognized health exposure that puts all critically
ill patients at risk. They may have potential roles in critical illness
as biologic markers or active contributors to specific adverse
outcomes. Although no causal relationship can be inferred from
these results, the strength of independent association is such that it
is reasonable to reconsider the role that viral infections play in the
outcomes of immunocompetent ICU patients. Prospective studies
should aid in confirming or redefining the role of viral infections
among all critically ill patients.
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